• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    American Airlines, CAVA Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

    5/29/24 5:16:17 AM ET
    $AAL
    $CAVA
    $CWCO
    $GME
    Air Freight/Delivery Services
    Consumer Discretionary
    Restaurants
    Consumer Discretionary
    Get the next $AAL alert in real time by email

    U.S. stock futures were lower this morning, with the Dow futures falling around 150 points on Wednesday.

    Shares of American Airlines Group Inc. (NASDAQ:AAL) fell sharply in today's pre-market trading after the company announced the departure of its executive vice president and lowered guidance for the second quarter.

    After the market close on Tuesday, American Airlines said Executive Vice President and Chief Commercial Officer Vasu Raja will depart the company in June.

    American Airlines shares dipped 7.2% to $12.47 in pre-market trading.

    Here are some big stocks recording losses in today's pre-market trading session.

    • Latam Logistic Properties, S.A. (NYSE:LPA) shares dipped 12% to $24.65 in pre-market trading after jumping around 99% on Tuesday.
    • NuScale Power Corporation (NYSE:SMR) shares fell 5% to $9.01 in pre-market trading after surging around 22% on Tuesday.
    • Oklo Inc. (NYSE:OKLO) shares declined 4.5% to $10.30 in pre-market trading after gaining 6% on Tuesday.
    • Novavax, Inc. (NASDAQ:NVAX) shares fell 4.5% to $14.81 in pre-market trading.
    • Consolidated Water Co. Ltd (NASDAQ:CWCO) shares fell 4.4% to $25.47 in pre-market trading after declining over 4% on Tuesday.
    • GameStop Corp. (NYSE:GME) shares fell 3.9% to $22.85 in pre-market trading. GameStop shares jumped over 25% on Tuesday after the company announced the completion of its at-the-market equity offering program.
    • CAVA Group, Inc. (NYSE:CAVA) shares declined 3.5% to $79.49 in pre-market trading following first-quarter results.

    Now Read This: Fear & Greed Index In ‘Neutral’ Zone; Nasdaq Settles Above 17,000

    Don't forget to check out our premarket coverage here

    Get the next $AAL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAL
    $CAVA
    $CWCO
    $GME

    CompanyDatePrice TargetRatingAnalyst
    CAVA Group Inc.
    $CAVA
    3/30/2026$91.00Neutral
    BNP Paribas Exane
    CAVA Group Inc.
    $CAVA
    3/26/2026$100.00Buy
    Guggenheim
    CAVA Group Inc.
    $CAVA
    3/9/2026$93.00Outperform
    Wolfe Research
    CAVA Group Inc.
    $CAVA
    3/6/2026$80.00Neutral
    DA Davidson
    American Airlines Group Inc.
    $AAL
    3/5/2026$12.50Buy → Neutral
    Rothschild & Co Redburn
    CAVA Group Inc.
    $CAVA
    2/27/2026Buy → Hold
    Argus
    NuScale Power Corporation
    $SMR
    2/27/2026$21.00Market Perform → Outperform
    Northland Capital
    CAVA Group Inc.
    $CAVA
    2/25/2026$85.00 → $88.00Outperform
    Telsey Advisory Group
    More analyst ratings

    $AAL
    $CAVA
    $CWCO
    $GME
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    American Airlines marks 40 years of partnership with the American Red Cross

    Support has helped advance disaster relief and humanitarian aidWASHINGTON, April 1, 2026 /PRNewswire/ -- For four decades, American Airlines has stood alongside the American Red Cross, helping ensure that when disasters strike, help is never out of reach. American has been a Red Cross Mission Leader since 2023, joining the organization's most elite group of donors — those giving more than $3 million annually to help alleviate suffering in the face of emergencies. For generations, the Red Cross has stepped forward to provide comfort, care and critical support to families facing e

    4/1/26 1:56:00 PM ET
    $AAL
    Air Freight/Delivery Services
    Consumer Discretionary

    Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

    Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical OfficerDr. Walker will continue advancing Novavax's R&D efforts with a focus on data generation to facilitate partnering discussions, Matrix adjuvant innovation and advancement of the Company pipeline  GAITHERSBURG, Md., March 30, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced the appointment of Dr. Robert Walker, MD, as Executive Vice President and Head of Research & Development (R&D). Dr. Walker now reports to John C. Jacobs, President and Chief Executive Officer of Novavax.A specialist in internal medicine and pulmonary and critical care medi

    3/30/26 8:00:00 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Oklo, Blykalla to Expand Strategic Partnership Through U.S. Investment and Collaboration

    Oklo Inc. (NYSE:OKLO) ("Oklo") and Blykalla AB ("Blykalla"), advanced nuclear technology companies from the U.S. and Sweden respectively, today announced an expansion of their transatlantic strategic partnership to broaden collaboration on fast reactor commercialization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330377076/en/Blykalla SEALER building (Image: Blykalla) Blykalla—which last year raised $50 million in capital to accelerate the industrialization and commercialization of its advanced lead-cooled reactor, the SEALER—aims to deploy capital and engineering resources in the U.S. through this collaboration. Resource

    3/30/26 8:00:00 AM ET
    $OKLO
    Electric Utilities: Central
    Utilities

    $AAL
    $CAVA
    $CWCO
    $GME
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BNP Paribas Exane initiated coverage on CAVA Group with a new price target

    BNP Paribas Exane initiated coverage of CAVA Group with a rating of Neutral and set a new price target of $91.00

    3/30/26 8:17:53 AM ET
    $CAVA
    Restaurants
    Consumer Discretionary

    Guggenheim initiated coverage on CAVA Group with a new price target

    Guggenheim initiated coverage of CAVA Group with a rating of Buy and set a new price target of $100.00

    3/26/26 8:46:57 AM ET
    $CAVA
    Restaurants
    Consumer Discretionary

    Wolfe Research initiated coverage on CAVA Group with a new price target

    Wolfe Research initiated coverage of CAVA Group with a rating of Outperform and set a new price target of $93.00

    3/9/26 9:06:39 AM ET
    $CAVA
    Restaurants
    Consumer Discretionary

    $AAL
    $CAVA
    $CWCO
    $GME
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    President, CEO and Chairman Cohen Ryan bought $21,359,200 worth of shares (1,000,000 units at $21.36), increasing direct ownership by 3% to 38,347,842 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/22/26 4:02:03 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    Director Attal Alain bought $259,577 worth of shares (12,000 units at $21.63), increasing direct ownership by 2% to 596,464 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/21/26 6:32:09 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $AAL
    $CAVA
    $CWCO
    $GME
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    October 3, 2023 - FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants

    For Immediate Release: October 03, 2023 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA CO

    10/3/23 2:56:27 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AAL
    $CAVA
    $CWCO
    $GME
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Moore Daniel William

    4 - GameStop Corp. (0001326380) (Issuer)

    4/3/26 5:11:59 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    SEC Form 4 filed by Robinson Mark Haymond

    4 - GameStop Corp. (0001326380) (Issuer)

    4/3/26 5:10:46 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    SEC Form 4 filed by Bealmear Richard Craig

    4 - Oklo Inc. (0001849056) (Issuer)

    4/3/26 4:36:40 PM ET
    $OKLO
    Electric Utilities: Central
    Utilities

    $AAL
    $CAVA
    $CWCO
    $GME
    SEC Filings

    View All

    SEC Form 144 filed by GameStop Corporation

    144 - GameStop Corp. (0001326380) (Subject)

    4/1/26 9:50:27 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    SEC Form 144 filed by Oklo Inc.

    144 - Oklo Inc. (0001849056) (Subject)

    3/27/26 1:49:56 PM ET
    $OKLO
    Electric Utilities: Central
    Utilities

    Amendment: SEC Form SCHEDULE 13G/A filed by Novavax Inc.

    SCHEDULE 13G/A - NOVAVAX INC (0001000694) (Subject)

    3/27/26 11:06:41 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAL
    $CAVA
    $CWCO
    $GME
    Financials

    Live finance-specific insights

    View All

    GameStop Reports Fourth Quarter and Fiscal Year 2025 Results

    GameStop Corp. (NYSE:GME) ("GameStop" or the "Company") today released financial results for the fourth quarter and fiscal year ended January 31, 2026. The Company's consolidated financial statements, including GAAP and non-GAAP results, are below. The Company's Form 10-K and supplemental information can be found at https://investor.gamestop.com. FOURTH QUARTER OVERVIEW Net sales were $1.104 billion for the fourth quarter, compared to $1.283 billion in the prior year's fourth quarter. Selling, general and administrative ("SG&A") expenses were $241.5 million for the fourth quarter, compared to $282.5 million in the prior year's fourth quarter. Operating income was $135.2 million f

    3/24/26 4:02:00 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    Logistic Properties of the Americas Announces Full-Year 2025 Earnings Results

    Company Accelerates Growth, Reflected in Revenue Increase of 23.3% in 4Q25 and 14.3% in 2025 NOI Increases 29.8% in 4Q25 and 11.9% for the Year Logistic Properties of the Americas (NYSE:LPA) (together with its subsidiaries, "LPA" or "the Company"), announced today its audited consolidated financial results for the year ended December 31, 2025 ("FY25"). The financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB"), which differ in certain significant respects from the U.S. Generally Accepted Accounting Principles ("GAAP"). This information sho

    3/18/26 4:33:00 PM ET
    $LPA
    Real Estate
    Finance

    Oklo Publishes Full-Year 2025 Financial Results and Business Update

    Oklo Inc. (NYSE:OKLO) ("Oklo" or "the Company"), an advanced nuclear technology company, today published its financial results and business update for the quarter and year ended December 31, 2025. Oklo will host a conference call today, March 17, 2026, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. Jacob DeWitte, Co-Founder and Chief Executive Officer, and Craig Bealmear, Chief Financial Officer, will speak on the call. A webcast of the call can be accessed by visiting the Events & Presentations section of the Company's investor relations website. An archive of the webcast will be available shortly after the conclusion of the event and will be available for 12 months. About Oklo

    3/17/26 4:00:00 PM ET
    $OKLO
    Electric Utilities: Central
    Utilities

    $AAL
    $CAVA
    $CWCO
    $GME
    Leadership Updates

    Live Leadership Updates

    View All

    Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

    Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical OfficerDr. Walker will continue advancing Novavax's R&D efforts with a focus on data generation to facilitate partnering discussions, Matrix adjuvant innovation and advancement of the Company pipeline  GAITHERSBURG, Md., March 30, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced the appointment of Dr. Robert Walker, MD, as Executive Vice President and Head of Research & Development (R&D). Dr. Walker now reports to John C. Jacobs, President and Chief Executive Officer of Novavax.A specialist in internal medicine and pulmonary and critical care medi

    3/30/26 8:00:00 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Oklo Co-Founder and CEO Appointed to Serve on President's Council of Advisors on Science and Technology

    Oklo Inc. (NYSE:OKLO) ("Oklo," or "the Company"), an advanced nuclear technology company, today announced that Oklo's CEO and co-founder Jacob DeWitte has been appointed by U.S. President Donald J. Trump to serve on the President's Council of Advisors on Science and Technology (PCAST) alongside America's leaders from science, engineering, and industry. "Oklo's Chief Operating Officer and co-founder Caroline DeWitte and I started this company 13 years ago, and every day we're proud, humbled, and excited by this journey," said DeWitte. "I believe deeply in American ingenuity and leadership, and I am honored to join the President's Council. I look forward to collaborating with my fellow coun

    3/25/26 5:27:00 PM ET
    $OKLO
    Electric Utilities: Central
    Utilities

    Cineverse and GameStop Invite Fans to 'Return to Silent Hill' with Innovative Partnership featuring Mysterious Messages, Exclusive Rewards, In-Store Media & More

    Return to Silent Hill Hits Theaters Nationwide on January 23 – Buy Tickets Now LOS ANGELES and GRAPEVINE, Texas, Jan. 14, 2026 /PRNewswire/ -- Cineverse (NASDAQ:CNVS), a next generation entertainment studio, and GameStop Corp. (NYSE:GME), are pulling out all the stops in anticipation of the January 23 wide theatrical release of Return to Silent Hill (returntosilenthillmovie.com).  The two companies are collaborating on an immersive marketing campaign for the new film, based on the visionary video game, SILENT HILL 2. Since January 7, fans who visit a participating GameStop ca

    1/14/26 3:02:00 PM ET
    $CNVS
    $GME
    Consumer Electronics/Video Chains
    Consumer Discretionary
    Electronics Distribution

    $AAL
    $CAVA
    $CWCO
    $GME
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by NuScale Power Corporation

    SC 13D/A - NUSCALE POWER Corp (0001822966) (Subject)

    11/27/24 7:35:05 AM ET
    $SMR
    Metal Fabrications
    Industrials

    Amendment: SEC Form SC 13D/A filed by Oklo Inc.

    SC 13D/A - Oklo Inc. (0001849056) (Subject)

    11/21/24 4:30:24 PM ET
    $OKLO
    Electric Utilities: Central
    Utilities

    Amendment: SEC Form SC 13G/A filed by Oklo Inc.

    SC 13G/A - Oklo Inc. (0001849056) (Subject)

    11/14/24 4:15:21 PM ET
    $OKLO
    Electric Utilities: Central
    Utilities